Tetraphase Pharmaceuticals, Inc.
(NASDAQ : TTPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 1.56%82.052.1%$228.74m
SAVACassava Sciences, Inc. 18.13%11.470.0%$208.15m
JAZZJazz Pharmaceuticals Plc 1.11%139.582.4%$169.45m
HZNPHorizon Therapeutics Plc 3.88%78.255.8%$167.25m
MRNSMarinus Pharmaceuticals, Inc. 4.21%11.157.8%$124.96m
CORTCorcept Therapeutics, Inc. 1.88%17.095.5%$120.14m
VRXValeant Pharmaceuticals International, Inc. 0.53%15.3014.1%$90.03m
BHCBausch Health Cos., Inc. 0.53%15.300.0%$61.37m
MYOKMyoKardia, Inc. 2.08%132.721.8%$59.58m
AMRNAmarin Corp. Plc 4.67%3.811.5%$56.78m
ARGXargenx SE 2.26%248.570.0%$56.59m
SAGESAGE Therapeutics, Inc. 3.26%60.828.6%$46.31m
GWPHGW Pharmaceuticals Plc 1.97%100.446.2%$39.53m
AXSMAxsome Therapeutics, Inc. 1.44%77.021.9%$39.11m
ICLRICON plc 2.30%183.144.3%$36.29m

Company Profile

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.